Beam Therapeutics
Cambridge, US · 4 known investors
Beam Therapeutics develops gene-editing medicines, particularly base editors and precision genome editing technologies, to create lifelong cures for patients with serious genetic diseases. The company works across multiple therapeutic areas to advance precision medicine treatments at the molecular level.
BiotechDeep TechMedical Devices
Founders & leadership
JE
John EvansCEO
DR
David R. LiuFounder and Inventor
JK
J. Keith JoungFounder and Inventor
FZ
Feng ZhangFounder and Inventor
Investors · 4
In the news
- Prime Medicine claims victory in dispute over gene-editing technology with Beam Therapeuticsstatnews.com · 2026
- Following FDA Clearance, Is Beam Therapeutics (BEAM) Already Priced In? - Simply Wall St Newssimplywall.st · 2026
- BEAM Stock | Beam Therapeutics, Inc. Price, Quote, News & Analysis - TipRanks.comtipranks.com · 2026
- How To Invest In Beam Therapeutics Inc Stock - BEAM Share Price Today & News | Stashstash.com · 2026
- Beam Therapeutics - 2026 Company Profile, Team, Funding, Competitors & Financials - Tracxntracxn.com · 2021